YOUR SEARCH FOR Text 28 RESULTS
21 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… a new therapeutic option for the approximately 150,000 mild to moderate HS patients in the U.S. …
22 of Total
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
Press Release View all news Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs August 3, 2021 at 8:00
23 of Total
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… Other intangible assets, net 134,603 150,755 Goodwill 155,593 155,593 Deferred …
24 of Total
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
Press Release View all news Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs October 31, 2023 at 7:
25 of Total
Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
Press Release View all news Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs May 2, 2023 at 7:00 AM
26 of Total
… 144: Filer Information Filer CIK 0001502917 Filer CCC XXXXXXXX Is this a LIVE or …
27 of Total
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Canc
Press Release View all news Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D
28 of Total
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
Press Release View all news Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs November 2, 2021 at 8: